|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12,100 GBX | -0.03% |
|
+1.31% | +14.15% |
| 07-15 | Global markets live: Airbus, Burberry, AT&T, Boeing, Vinfast... |  |
| 07-15 | AstraZeneca: acquisition of Amolyt Pharma finalized | CF |
Jan 2 (Reuters) - AstraZeneca and Sanofi's respiratory syncytial virus (RSV) immunization for infants has been approved in China, the London-listed drugmaker said on Tuesday.
(Reporting by Eva Mathews in Bengaluru; Editing by Dhanya Ann Thoppil)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 12,100 GBX | -0.03% | +1.31% | 244B | ||
| 2,904 PTS | +0.34% | +0.31% | - | ||
| 91.92 EUR | -0.55% | -0.12% | 126B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +14.15% | 244B | |
| +62.14% | 856B | |
| +38.95% | 631B | |
| -3.97% | 359B | |
| +15.78% | 325B | |
| +8.93% | 297B | |
| +5.89% | 234B | |
| +16.53% | 226B | |
| +16.10% | 177B | |
| +2.17% | 165B |
ASTRAZENECA PLC 
